BEGIN:VCALENDAR
PRODID:-//AddEvent Inc//AddEvent.com v1.7//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
DTSTART:19691231T170000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Join National Jewish Health for a complimentary CME breakfast at CHEST 2026. Register at NJHealth.org/ILDTreatment http://NJHealth.org/ILDTreatment\n\nFibrosing ILD is evolving rapidly\, with new and emerging therapies changing how clinicians identify progression\, select treatment\, and coordinate care. This interactive CME breakfast symposium will bring together experts in pulmonology\, rheumatology\, and radiology to tackle real-world challenges in ILD management through practical\, case-based discussion.\n\nUsing HRCT findings and multidisciplinary perspectives\, faculty will explore how to recognize progressive pulmonary fibrosis\, determine when to initiate or adjust therapy\, balance immunomodulatory and antifibrotic strategies\, and apply emerging evidence to patient care. Attendees will leave with actionable strategies to improve decision-making and optimize outcomes for patients with complex fibrosing ILD.\n\n1.0 CME/MOC\n\nFaculty:\nMelissa Griffith\, MD\, RhMSUS\nUniversity of Colorado School of Medicine\n\nDavid A. Lynch\, MB BCh\nNational Jewish Health\n\nJoshua J. Solomon\, MD\nNational Jewish Health
X-ALT-DESC;FMTTYPE=text/html:<strong>Join National Jewish Health for a complimentary CME breakfast at CHEST 2026. Register at </strong><a href="http://NJHealth.org/ILDTreatment" target="_blank" rel="noopener noreferrer"><strong>NJHealth.org/ILDTreatment</strong></a><br><br>Fibrosing ILD is evolving rapidly, with new and emerging therapies changing how clinicians identify progression, select treatment, and coordinate care. This interactive CME breakfast symposium will bring together experts in pulmonology, rheumatology, and radiology to tackle real-world challenges in ILD management through practical, case-based discussion.<br><br>Using HRCT findings and multidisciplinary perspectives, faculty will explore how to recognize progressive pulmonary fibrosis, determine when to initiate or adjust therapy, balance immunomodulatory and antifibrotic strategies, and apply emerging evidence to patient care. Attendees will leave with actionable strategies to improve decision-making and optimize outcomes for patients with complex fibrosing ILD.<br><br>1.0 CME/MOC<br><br>Faculty:<br />Melissa Griffith, MD, RhMSUS<br />University of Colorado School of Medicine<br><br>David A. Lynch, MB BCh<br />National Jewish Health<br><br>Joshua J. Solomon, MD<br />National Jewish Health
UID:e093be6bc24c4d63a869165608574a99addeventcom
SUMMARY:Navigating the Evolving Treatment Landscape in Fibrosing ILD: A Multidisciplinary Case-Based Approach
DTSTART;TZID=America/Phoenix:20261020T063000
DTEND;TZID=America/Phoenix:20261020T073000
DTSTAMP:20260625T031436Z
TRANSP:OPAQUE
STATUS:CONFIRMED
SEQUENCE:0
LOCATION:Sheraton Phoenix Downtown \nPhoenix Ballroom D&E\n340 N 3rd St\, Phoenix\, 85004\, AZ\, USA
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
BEGIN:VALARM
TRIGGER:-PT60M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR